Status:
COMPLETED
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
Lead Sponsor:
Oregon Health and Science University
Conditions:
Respiratory Distress Syndrome
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP)...
Eligibility Criteria
Inclusion
- Gestational age at birth \<33 weeks
- Required CPAP for a minimum of 24 hours for respiratory distress
- Patient on CPAP and room air at time of randomization
Exclusion
- Complex congenital heart disease other than patent ductus arteriosus or atrial septal defect
- Major malformations or chromosomal anomalies
- Multiple gestation greater than twins
- Culture proven sepsis or unstable at time of randomization
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02249143
Start Date
September 1 2014
End Date
September 1 2017
Last Update
August 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239